Decreased drug reporting in a cross-sectional student drug use survey

被引:26
|
作者
Fendrich, M [1 ]
Mackesy-Amiti, ME [1 ]
机构
[1] Univ Illinois, Dept Psychiat, Inst Juvenile Res, Chicago, IL 60612 USA
关键词
D O I
10.1016/S0899-3289(00)00018-3
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Purpose, longitudinal cohort studies have suggested that reinterviews about drug use often lead to decreased reports of lifetime substance use (recanting). Respondents may, edit their answers on reinterview because of perceptions regarding question threat. Since reinterviews usually occur after long periods of time, the influence of inadequate recall (memory), cannot be ruled out. In order to evaluate the relative importance of editing and memory on recanting we examined a cross-sectional administered in 1993 to a probability sample of Illinois students who were in the 7th through 12th grade. Methods. Two sets of self-administered survey questions assessed drug use. the I-SAY drug-use questionnaire, and a supplemental questionnaire asked at the end of the mail? survey We compared the rates of "new use " (ilo use for a drug reported in the I-SAY use reported for a drug on the supplement) with rates of recanting (use for a drug reported on the I-SAY: no use for a drug reported on the supplement). Results, Recanting was generally more pronounced than new use, especially for cocaine, heroin, marijuana, and inhalants. Those classified as light or inconsistent users on the I-SAY were significantly more likely to recant their drug use reports.
引用
收藏
页码:161 / 172
页数:12
相关论文
共 50 条
  • [2] 6 YEARS OF CROSS-SECTIONAL SURVEYS OF STUDENT DRUG-USE IN TORONTO
    SMART, RG
    FEJER, D
    BULLETIN ON NARCOTICS, 1975, 27 (02) : 11 - 22
  • [3] Knowledge of Adverse Drug Reaction Reporting Among Healthcare Professionals in Bhutan: A Cross-Sectional Survey
    Choki Dorji
    Pramote Tragulpiankit
    Arthorn Riewpaiboon
    Tashi Tobgay
    Drug Safety, 2016, 39 : 1239 - 1250
  • [4] Community pharmacists’ knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey
    Raymond Li
    Colin Curtain
    Luke Bereznicki
    Syed Tabish Razi Zaidi
    International Journal of Clinical Pharmacy, 2018, 40 : 878 - 889
  • [5] Community pharmacists' knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey
    Li, Raymond
    Curtain, Colin
    Bereznicki, Luke
    Zaidi, Syed Tabish Razi
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (04) : 878 - 889
  • [6] Knowledge of Adverse Drug Reaction Reporting Among Healthcare Professionals in Bhutan: A Cross-Sectional Survey
    Dorji, Choki
    Tragulpiankit, Pramote
    Riewpaiboon, Arthorn
    Tobgay, Tashi
    DRUG SAFETY, 2016, 39 (12) : 1239 - 1250
  • [7] Patient Reporting of Adverse Drug Reactions in Romania-Pilot Phase of a Cross-Sectional Survey
    Bucsa, C.
    Cazacu, I.
    Mogosan, C.
    Bulik, N.
    Axente, B.
    Farcas, A.
    DRUG SAFETY, 2018, 41 (11) : 1195 - 1196
  • [8] Consumer views on the use of digital tools for reporting adverse drug reactions: a cross-sectional study
    Dedefo, Mohammed Gebre
    Lim, Renly
    Kassie, Gizat M.
    Gebreyohannes, Eyob Alemayehu
    Salekdeh, Nava Nikpay
    Roughead, Elizabeth
    Kalisch Ellett, Lisa
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2025, 47 (02) : 423 - 434
  • [9] REPORTING QUALITY OF DRUG SAFETY SYSTEMATIC REVIEWS: A CROSS-SECTIONAL STUDY
    Li, L.
    Xu, C.
    Deng, K.
    Zhou, X.
    Sun, X.
    VALUE IN HEALTH, 2018, 21 : S85 - S85
  • [10] Factors associated with the use of benzodiazepine and opioid prescription drug in the student population: a cross-sectional study
    Thomas, Charlotte
    Dondaine, Thibaut
    Caron, Clement
    Bastien, Axel
    Cherot, Nathalie
    Deheul, Sylvie
    Gautier, Sophie
    Cottencin, Olivier
    Moreau-Crepeaux, Sophie
    Bordet, Regis
    Carton, Louise
    SCIENTIFIC REPORTS, 2024, 14 (01):